Last reviewed · How we verify

NCT06298617

Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis

Completed Last updated 12 March 2024
What this trial tests

trial testing Diagnostic laparoscopy in Endometriosis in 88 participants. Completed in 25 December 2023.

Timeline
1 January 2023
Primary endpoint
30 July 2023
25 December 2023

Quick facts

Lead sponsorBenha University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment88
Start date1 January 2023
Primary completion30 July 2023
Estimated completion25 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Benha University

Who can join

Adults 25 to 50, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endometriosis (EMs) is one of the commonest chronic inflammatory disorder affecting women and is characterized by the presence and growth of endometrial-like glandular epithelial and stromal cells outside the uterus leading to multiple clinical symptoms affecting patients quality of life and fertility with high recurrence rate . The systemic immune inflammatory index (SII) and systemic inflammatory response index (SIRI) are documented as prognostic serum biomarker in many kinds of cancer and for the need and outcomes of adjuvant therapies for various cancers .

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Systemic inflammatory indices as a non-invasive grading modality for endometriosis: a comparative study versus exploratory laparoscopy.
    Sabra ASIM, Moselhy SNA, Eldin AKMZ. · · 2024 · cited 1× · PMID 39669306 · DOI 10.61622/rbgo/2024rbgo84

Verify or expand the search:

Other trials of Diagnostic laparoscopy

Trials testing the same drug.

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Benha University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06298617.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing